Biomarkers for Ovarian cancer

1. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. WFDC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. BRIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. ZNF198
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. ERCC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. BUB1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. MECOM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. FANCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. PPP2R1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. RAD51B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. PIM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. PMS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. DROSHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. MUTYH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. AXIN2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. CDK12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. BMPR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. FOXA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. FOXP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. NCOR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. PTK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. SEPT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. HNF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. LCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. SFRP4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. TOP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. FANCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. HOXA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. JAZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. PTPN13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. SPECC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. CYP2D6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. BCL9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. DDB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. JAK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. NCOA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. NUP214
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. PPARG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. TRRAP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. WHSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. BCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. COL1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. HERPUD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. SMARCE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. TBL1XR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. TSHR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. UBR5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. WRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. APOBEC3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. ARHGAP26
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. BTG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
307. CCND3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
308. CHD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
309. DDX3X
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
310. DNAJB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
311. FCGR2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
312. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
313. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
314. IRF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
315. KMT2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
316. LASP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
317. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
318. PLCG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
319. PRDM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
320. RAD21
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
321. RNF43
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
322. SLC34A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
323. SRSF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
324. TET2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
325. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
326. TNFRSF17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
327. CEP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
328. ARID2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
329. BCL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
330. BCL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
331. BTK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
332. CHIC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
333. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
334. DDX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
335. DDX6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
336. EBF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
337. EML4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
338. FANCE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
339. GNA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
340. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
341. GRIN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
342. IKZF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
343. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
344. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
345. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
346. LPP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
347. LRP1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
348. MALAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
349. MKL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
350. NCOA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
351. PBX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
352. PRCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
353. QKI
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
354. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
355. RPL10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
356. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
357. SETBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
358. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
359. SH2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
360. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
361. TFG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
362. TNFRSF14
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
363. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
364. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
365. ZNF331
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
366. PAM50
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
367. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
368. ABI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
369. AKAP9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
370. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
371. BCOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
372. CANT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
373. COL2A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
374. CREB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
375. EIF3E
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
376. FAT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
377. H3F3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
378. HOXA13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
379. HOXD13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
380. HSP90AB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
381. KDM5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
382. KDM6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
383. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
384. MALT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
385. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
386. MED12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
387. MLLT11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
388. MLLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
389. MPL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
390. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
391. NCOA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
392. NCOR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
393. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
394. NUMA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
395. OMD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
396. PCM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
397. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
398. PICALM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
399. RANBP2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
400. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
401. SDC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
402. SSX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
403. TET1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
404. TMPRSS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
405. TPM3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
406. TRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
407. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
408. SET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
409. ACSL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
410. ACSL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
411. ACVR2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
412. AFF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
413. AMER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
414. ASXL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
415. BRD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
416. CARD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
417. CBFA2T3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
418. CBLC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
419. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
420. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
421. CEBPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
422. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
423. CNBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
424. CRTC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
425. DDR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
426. DDX10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
427. DEK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
428. DNM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
429. DUX4L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
430. EPAS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
431. EPS15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
432. ETNK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
433. ETV1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
434. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
435. FAT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
436. FGFR1OP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
437. GATA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
438. GMPS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
439. H3F3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
440. HLF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
441. HNRNPA2B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
442. HOXC13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
443. HOXD11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
444. IGL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
445. KCNJ5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
446. KDSR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
447. LMO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
448. LMO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
449. LSM14A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
450. MLLT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
451. MLLT10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
452. MNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
453. MSI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
454. NFIB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
455. NIN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
456. NONO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
457. NUP98
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
458. OLIG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
459. PAFAH1B2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
460. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
461. PAX7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
462. PBRM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
463. PHOX2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
464. POT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
465. PSIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
466. PTPRT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
467. RBM15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
468. RMI2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
469. RPL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
470. RSPO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
471. RSPO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
472. RUNX1T1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
473. SDHAF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
474. SEPT5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
475. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
476. SLC45A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
477. SMARCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
478. SPOP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
479. SRSF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
480. SSX4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
481. SUFU
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
482. TAL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
483. TBX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
484. TCEA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
485. TCF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
486. TCL1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
487. TPM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
488. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
489. TTL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
490. USP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
491. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
492. WWTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
493. ZFHX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
494. ZNF278
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
495. Cytokeratin fragment 21-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
496. IHC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
497. MK167
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
498. CD52
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
499. ACKR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
500. AFF3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
501. AFF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
502. ALDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
503. ARHGEF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
504. ASPSCR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
505. ATIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
506. ATP1A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
507. ATP2B3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
508. BCL11A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
509. BCL11B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
510. BCL5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
511. BCL7A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
512. BCL9L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
513. BCORL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
514. C12orf9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
515. C15orf65
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
516. C2orf44
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
517. CACNA1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
518. CAMTA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
519. CASC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
520. CBFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
521. CBLB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
522. CCNB1IP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
523. CD79B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
524. CEP89
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
525. CHCHD7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
526. CLP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
527. CLTC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
528. CLTCL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
529. CNOT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
530. CNTRL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
531. COX6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
532. CREB3L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
533. CREB3L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
534. CRLF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
535. CRTC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
536. CSF3R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
537. DCTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
538. ECT2L
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
539. EIF4A2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
540. ELK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
541. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
542. ERC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
543. EXT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
544. EZR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
545. FAM131B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
546. FAM46C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
547. FBXO11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
548. FCRL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
549. FIP1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
550. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
551. FNBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
552. FOXO4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
553. FSTL3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
554. GAS7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
555. GATA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
556. GOLGA5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
557. GPHN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
558. HIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
559. HIST1H3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
560. HIST1H4I
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
561. HMGN2P46
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
562. HOOK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
563. HOXC11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
564. IGK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
565. IKBKB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
566. IL21R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
567. KAT6A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
568. KAT6B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
569. KDM5C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
570. KIAA1549
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
571. KIAA1598
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
572. KIF5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
573. KTN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
574. LHFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
575. LRIG3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
576. LYL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
577. LZTR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
578. MAFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
579. MAML2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
580. MAP3K13
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
581. MDS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
582. MLF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
583. MLLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
584. MLLT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
585. MN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
586. MTCP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
587. MYH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
588. MYH9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
589. MYO5A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
590. NAB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
591. NACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
592. NFATC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
593. NFKB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
594. NFKBIE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
595. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
596. NUTM2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
597. NUTM2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
598. P2RY8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
599. PDE4DIP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
600. PHF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
601. PLAG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
602. POU2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
603. PPP6C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
604. PRDM16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
605. PREX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
606. PRKACA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
607. PRRX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
608. PTPRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
609. PTPRK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
610. PWWP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
611. RABEP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
612. RALGDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
613. RANBP17
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
614. RAP1GDS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
615. RBM10
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
616. RNF213
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
617. RNF217-AS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
618. RPN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
619. RUNDC2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
620. SBDS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
621. SEPT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
622. SETD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
623. SH3GL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
624. SRGAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
625. SS18L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
626. STAG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
627. STRN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
628. TAF15
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
629. TCF12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
630. TCL6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
631. TFEB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
632. TFPT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
633. THRAP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
634. TLX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
635. TLX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
636. TMEM127
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
637. TRAF7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
638. TRD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
639. TRIM24
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
640. TRIM33
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
641. TRIP11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
642. USP6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
643. VTI1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
644. WHSC1L1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
645. ZCCHC8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
646. ZNF384
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
647. ZNF521
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
648. ZRSR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
649. MAP-Tau mRNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
650. Nuclear matrix protein 22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
651. CAD-ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]